Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose?Maria Adriana Cocozza, Lorenzo Braccischi, Antonio De Cinque, et al.
United European Gastroenterology Journal|February 22, 2019
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinomaElisabetta Sagrini, Massimo Iavarone, Federico Stefanini, et al.
Cancers|September 23, 2020
Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular CarcinomaCatia Giovannini, Francesca Fornari, Valentina Indio, et al.
Gland Surgery|August 11, 2020
Outcomes following minimally invasive imagine-guided percutaneous ablation of adrenal glandsAnna Maria Ierardi, Aldo Carnevale, Salvatore Alessio Angileri, et al.
Journal of Hepatology|September 2, 2015
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinomaAlessandro Cucchetti, Matteo Cescon, Rita Golfieri, et al.
Medical Oncology (Northwood, London, England)|March 14, 2020
Ablation for hepatocellular carcinoma: beyond the standard indicationsMatteo Renzulli, Francesco Tovoli, Alfredo Clemente, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
Expert Review of Gastroenterology & Hepatology|November 16, 2020
Clinical impact of sarcopenia assessment in patients with liver cirrhosisGiovanni Marasco, Elton Dajti, Federico Ravaioli, et al.
European Radiology|September 13, 2017
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosisMatteo Renzulli, Federica Buonfiglioli, Fabio Conti, et al.
Pageof 16